Last reviewed · How we verify
prevention of invasive pneumococcal disease caused by 15 serotypes of streptococcus pneumoniae in adults 18 years of age and older with functional or anatomic asplenia
Approved treatments
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- prevention of invasive pneumococcal disease caused by 15 serotypes of streptococcus pneumoniae in adults 18 years of age and older with functional or anatomic asplenia patent landscape — cliff calendar, originator estates, attackable patents
- prevention of invasive pneumococcal disease caused by 15 serotypes of streptococcus pneumoniae in adults 18 years of age and older with functional or anatomic asplenia treatment landscape brief
- prevention of invasive pneumococcal disease caused by 15 serotypes of streptococcus pneumoniae in adults 18 years of age and older with functional or anatomic asplenia treatment updates RSS
Related
- Treatment landscape: prevention of invasive pneumococcal disease caused by 15 serotypes of streptococcus pneumoniae in adults 18 years of age and older with functional or anatomic asplenia patent cliff · prevention of invasive pneumococcal disease caused by 15 serotypes of streptococcus pneumoniae in adults 18 years of age and older with functional or anatomic asplenia CI report
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing